We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

112 hedge funds and large institutions have $633M invested in Cogent Biosciences in 2022 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 43 increasing their positions, 19 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

208% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 13

126% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 19

81% more capital invested

Capital invested by funds: $349M → $633M (+$284M)

80% more funds holding in top 10

Funds holding in top 10: 5 → 9 (+4)

29% more funds holding

Funds holding: 87 → 112 (+25)

7.24% more ownership

Funds ownership: 103.08% → 110.32% (+7.2%)

10% less call options, than puts

Call options by funds: $2.12M | Put options by funds: $2.35M

Holders
112
Holders Change
+25
Holders Change %
+28.74%
% of All Funds
1.89%
Holding in Top 10
9
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+80%
% of All Funds
0.15%
New
40
Increased
43
Reduced
19
Closed
13
Calls
$2.12M
Puts
$2.35M
Net Calls
-$237K
Net Calls Change
-$240K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$29.2M
2
VA
VR Adviser
New York
+$20.1M
3
CC
Commodore Capital
New York
+$9.86M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$8.37M
5
FFM
Fairmount Funds Management
Pennsylvania
+$8.19M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$7.06M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.39M
3
GTC
Ghost Tree Capital
New York
-$5.46M
4
FLSM
Frazier Life Sciences Management
California
-$3.81M
5
CS
Candriam SCA
Luxembourg
-$3.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$8.06M +$6.02M +881,334 +7,190%
ABG
27
Ally Bridge Group
New York
$7.73M -$3.09M -452,078 -35%
SCM
28
Silverarc Capital Management
Massachusetts
$7.41M +$1.69M +247,255 +43%
CAM
29
Cormorant Asset Management
Massachusetts
$6.76M +$5.12M +750,000 New
Geode Capital Management
30
Geode Capital Management
Massachusetts
$6.66M +$964K +141,262 +24%
State Street
31
State Street
Massachusetts
$6.26M +$468K +68,523 +11%
SCM
32
Suvretta Capital Management
New York
$5.41M +$4.1M +600,000 New
Axa
33
Axa
France
$5.28M -$77.8K -11,400 -2%
NLVP
34
New Leaf Venture Partners
New York
$4.52M – – –
AVAI
35
Atlas Venture Associates IX
Massachusetts
$4.21M -$3.07M -450,000 -49%
Millennium Management
36
Millennium Management
New York
$4.04M +$2.81M +411,773 +1,148%
BC
37
Boxer Capital
California
$3.83M +$2.9M +425,000 New
Goldman Sachs
38
Goldman Sachs
New York
$3.34M +$1.3M +190,892 +107%
EI
39
EAM Investors
California
$3.3M +$2.5M +365,667 New
Northern Trust
40
Northern Trust
Illinois
$3.21M +$421K +61,741 +21%
JP Morgan Chase
41
JP Morgan Chase
New York
$3.21M +$1.31M +192,107 +117%
PHP
42
Parkman Healthcare Partners
Connecticut
$2.6M +$1.97M +288,750 New
Morgan Stanley
43
Morgan Stanley
New York
$2.5M +$1.78M +260,126 +1,528%
IC
44
Ikarian Capital
Texas
$2.26M +$1.71M +250,000 New
PVI
45
Pura Vida Investments
New York
$2.15M +$1.63M +238,787 New
PAMP
46
Polar Asset Management Partners
Ontario, Canada
$2.12M +$1.61M +235,500 New
Macquarie Group
47
Macquarie Group
Australia
$2.08M +$1.57M +230,000 New
SSA
48
Schonfeld Strategic Advisors
New York
$1.88M -$223K -32,700 -14%
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$1.77M +$1.34M +195,901 New
EGI
50
EAM Global Investors
California
$1.64M +$1.24M +181,581 New
1
2
3 4 5

COGT Hedge Fund Activity: Q2 2022 in Review

112 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q2 2022, worth a combined $633M — up 81% from $349M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new COGT positions and 13 closed out — a net gain of 27 holders — while 43 added to existing stakes and 19 trimmed.

The largest buyer was Deerfield Management, adding an estimated $29.2M. The largest seller was Janus Henderson Group, cutting an estimated $7.06M.

  • 112 institutional investors held Cogent Biosciences (COGT) as of Q2 2022, up from 87 in Q1 2022.
  • Funds reported $633M of Cogent Biosciences stock for Q2 2022, up 81% quarter-over-quarter.
  • 40 funds opened new Cogent Biosciences positions in Q2 2022 and 13 closed out, a net change of +27 holders.
  • The largest Cogent Biosciences buyer in Q2 2022 was Deerfield Management, an estimated $29.2M added.
  • The largest Cogent Biosciences seller in Q2 2022 was Janus Henderson Group, an estimated $7.06M sold.

Based on aggregated 13F filings for Q2 2022.